NOONAN SYNDROME PRESENTING GROWTH-HORMONE NEUROSECRETORY DYSFUNCTION

被引:29
|
作者
TANAKA, K
SATO, A
NAITO, T
KURAMOCHI, K
ITABASHI, H
TAKEMURA, Y
机构
[1] Department of Internal Medicine, Koshigaya Hospital, Dokkyo University School of Medicine, Koshigaya
关键词
DWARFISM; MENTAL RETARDATION; IGF-I; RECOMBINANT HUMAN GROWTH HORMONE;
D O I
10.2169/internalmedicine.31.908
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Noonan syndrome has been diagnosed by the characteristic physical stigmata for more than two decades. Recent studies of growth hormone secretory pattern provide a new category of growth hormone neurosecretory dysfunction to characterize short stature. We describe herein a case of growth hormone neurosecretory dysfunction in a 16-year-old boy with Noonan syndrome. Growth hormone neurosecretory dysfunction was diagnosed primarily based on the low amplitude and small numbers of the spontaneous bursts of growth hormone secretion during 12-hour nocturnal growth hormone sampling. Treatment with synthetic human growth hormone has markedly accelerated the growth velocity for one year and a half. This case notes the wide spectrum of short stature in Noonan syndrome and the effectiveness of treatment with human growth hormone.
引用
收藏
页码:908 / 911
页数:4
相关论文
共 50 条
  • [31] Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome
    Dahlgren, Jovanna
    Noordam, Cees
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [32] Growth Hormone Therapy in Noonan Syndrome: Growth Response and Characteristics
    Westphal, Otto
    HORMONE RESEARCH, 2009, 72 : 41 - 45
  • [33] Noonan Syndrome: Growth to Growth Hormone - The Experience of Observational Studies
    Ranke, Michael B.
    HORMONE RESEARCH, 2009, 72 : 36 - 40
  • [34] GROWTH-HORMONE (GH) THERAPY IN PRADER-WILLI SYNDROME (PWS) CHILDREN WITH NEUROSECRETORY GH DEFICIENCY
    ANGULO, M
    UY, J
    CANAS, A
    PALEKAR, A
    PEDIATRIC RESEARCH, 1990, 27 (04) : A128 - A128
  • [35] GROWTH-HORMONE DEFICIENCY AND GROWTH-HORMONE THERAPY IN ULLRICH-TURNER-SYNDROME
    BUTENANDT, O
    KLINISCHE WOCHENSCHRIFT, 1980, 58 (02): : 99 - 101
  • [36] Effectiveness of growth hormone therapy in children with Noonan syndrome
    Seok, Eun Mi
    Park, Hong Kyu
    Rho, Jung Gi
    Kum, Change Dae
    Lee, Hae Sang
    Hwang, Jin Soon
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 25 (03) : 182 - 186
  • [37] Noonan syndrome: from phenotype to growth hormone therapy
    Malaquias, Alexsandra C.
    Ferreira, We V.
    Souza, Silvia C.
    Arnhold, No J. P.
    Mendonqa, Berenice B.
    Jorge, Alexander A. L.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2008, 52 (05) : 800 - 808
  • [38] Noonan syndrome: Genetics and responsiveness to growth hormone therapy
    Binder, Gerhard
    Wittekindt, Nicola
    Ranke, Michael B.
    HORMONE RESEARCH, 2007, 67 : 45 - 49
  • [39] GROWTH-HORMONE RESPONSE TO GROWTH-HORMONE RELEASING HORMONE 1-40 IN TURNERS SYNDROME
    CAPPA, M
    LOCHE, S
    BORRELLI, P
    CORDA, R
    MARINI, R
    PORCEDDA, C
    PINTOR, C
    HORMONE RESEARCH, 1987, 27 (01) : 1 - 6
  • [40] Growth hormone neurosecretory dysfunction associated with ring chromosome 18
    Aritaki, S
    Takagi, A
    Someya, H
    Jun, L
    ACTA PAEDIATRICA JAPONICA, 1996, 38 (05): : 544 - 548